Our Scope

The CCMD Group assists in the production and maintenance of Cochrane reviews that assess the effects (including harm) of treatments in the prevention and management of a range of mental disorders.

Types of reviews: We primarily undertake intervention reviews, but we do also produce reviews using multiple treatment meta-analysis.

Below is a summary of our scope. Follow the links for our full list of conditions, psychological therapies, and antidepressant classifications 

·                     ADJUSTMENT DISORDERS 

·                     ANXIETY DISORDERS 

o   AGORAPHOBIA 

o   NEUROCIRCULATORY ASTHENIA 

o   OBSESSIVE-COMPULSIVE DISORDER 

o   PANIC DISORDER

o   GENERALIZED ANXIETY DISORDER (GAD)

o   PHOBIC DISORDERS

-        SOCIAL PHOBIA (Social Anxiety)  

o   STRESS DISORDERS, TRAUMATIC

-      COMBAT DISORDERS

-        STRESS DISORDERS POST-TRAUMATIC

-        STRESS DISORDERS, TRAUMATIC, ACUTE

·         EATING DISORDERS  

o   ANOREXIA NERVOSA

o   BINGE-EATING DISORDER

o   BULIMIA NERVOSA

o   COPROPHAGIA  

o   FEMALE ATHLETE TRIAD SYNDROME

o   PICA

o   EATING DISORDERS NOT OTHERWISE SPECIDIED (EDNOS)

·                    FACTITIOUS DISORDERS  

o   MUNCHAUSEN SYNDROME

o   MUNCHAUSEN SYNDROME BY PROXY

·                    IMPULSE CONTROL DISORDERS  

o   FIRESETTING BEHAVIOR 

o   GAMBLING 

o   TRICHOTILLOMANIA

o   INTERMITTENT EXPLOSIVE DISORDER

o   KLEPTOMANIA

·         MOOD DISORDERS 

o   AFFECTIVE DISORDERS, PSYCHOTIC 

- BIPOLAR DISORDER

-        CYCLOTHYMIC DISORDER 

o   DEPRESSIVE DISORDER  

-        DEPRESSION, POSTPARTUM  

-        DEPRESSIVE DISORDER, MAJOR  

-        DYSTYHMIC DISORDER

-         SEASONAL AFFECTIVE DISORDER 

·         NEUROTIC DISORDERS  

·         SEXUAL AND GENDER DISORDERS  

o        SEXUAL DYSFUNCTIONS, CAUSED BY MEDICATION 

-        ERECTILE DYSFUNCTION  

o        SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 

-        VAGINISMUS

·            SOMATOFORM DISORDERS 

o       BODY DYSMORPHIC DISORDERS

o       CONVERSION DISORDER

o       HYPOCHONDRIASIS

o       NEURASTHENIA  

o       SOMATIZATION DISORDER

o       SOMATOFORM PAIN DISORDER

o       UNDIFFERENTIATED SOMATOFORM DISORDERS (MUPS)

·         FATIGUE SYNDROME, CHRONIC  

·         SLEEP DISORDERS  

o   JET LAG SYNDROME 

o   SLEEP INITIATION AND MAINTENANCE DISORDERS (Primary Insomnia)

 

·         SELF INJURIOUS BEHAVIOR

o   SELF MUTILATION 

o   SUICIDE

SUICIDE, ATTEMPTED

Major conditions of interest 

Interventions commonly reviewed 

Anxiety disorders
e.g. obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD) 

Psychotherapies
e.g. cognitive-behavioural therapy (CBT), psychodynamic therapy
 

Eating disorders
e.g. anorexia nervosa, binge-eating disorder, bulimia nervosa 

Pharmacological treatments
e.g. antidepressant medication, antipsychotics
 

Impulse control disorders
e.g. gambling, kleptomania 

Alternative therapies
e.g. acupuncture, herbal remedies, reiki, massage
 

Mood disorders
e.g. bipolar disorder, depression, seasonal affective disorder (SAD) 

Organisational
e.g. collaborative care, work-based interventions, morita therapy, education
 

Somatoform disorders
e.g. hypochondriasis, neurasthenia 

Physical activities
e.g. exercise, tai chi
 

Sleep disorders
e.g. primary insomnia 

Neurosurgery and electroconvulsive therapy (ECT) 

Chronic fatigue syndrome 

Self-injurious behaviour
e.g. self harm, attempted suicide 

The scope of the group is wide, but excludes those aspects of mental health care covered by the following Cochrane groups:

The scope of our work means that we have interaction with the following Cochrane fields: